OAC
CYTK icon

OMERS Administration Corp’s Cytokinetics CYTK Stock Holding History

OMERS Administration Corp’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$690K Buy
+8,100
New +$582K ﹤0.01% 757
2024
Q2 		– Sell
-35,500
Closed -$2.49M – 1091
2024
Q1 		$2.49M Buy
35,500
+19,900
+128% +$1.54M 0.03% 115
2023
Q4 		$1.3M Buy
+15,600
New +$565K 0.02% 137

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's CYTK Position: Q2 2026 in Review

OMERS Administration Corp opened a new position in Cytokinetics (CYTK) in Q2 2026: 8,100 shares worth $690K. The stake represents ﹤0.01% of the portfolio and ranks #757 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in CYTK as recently as Q1 2024.

OMERS Administration Corp first reported a position in CYTK in Q4 2023 and has held it in 3 quarters since. The position peaked at $2.49M in Q1 2024. 483 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • OMERS Administration Corp held 8,100 shares of Cytokinetics worth $690K as of Q2 2026.
  • Cytokinetics was a new OMERS Administration Corp position in Q2 2026.
  • Cytokinetics made up ﹤0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #757 holding.
  • OMERS Administration Corp first reported a position in Cytokinetics in Q4 2023 and has held it in 3 quarters since.
  • OMERS Administration Corp's Cytokinetics position peaked at $2.49M in Q1 2024.
  • 483 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.